1134 related articles for article (PubMed ID: 27063264)
21. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Spengler EK; Loomba R
Mayo Clin Proc; 2015 Sep; 90(9):1233-46. PubMed ID: 26219858
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic fatty liver disease and cardiovascular disease.
Hyogo H; Chayama K; Yamagishi S
Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
[TBL] [Abstract][Full Text] [Related]
23. Recent Epidemiology of Nonalcoholic Fatty Liver Disease.
Murag S; Ahmed A; Kim D
Gut Liver; 2021 Mar; 15(2):206-216. PubMed ID: 32921636
[TBL] [Abstract][Full Text] [Related]
24. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
25. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
26. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.
Sherif ZA; Saeed A; Ghavimi S; Nouraie SM; Laiyemo AO; Brim H; Ashktorab H
Dig Dis Sci; 2016 May; 61(5):1214-25. PubMed ID: 27038448
[TBL] [Abstract][Full Text] [Related]
27. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.
Goyal NP; Schwimmer JB
Clin Liver Dis; 2016 May; 20(2):325-38. PubMed ID: 27063272
[TBL] [Abstract][Full Text] [Related]
28. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Watanabe S; Hashimoto E; Ikejima K; Uto H; Ono M; Sumida Y; Seike M; Takei Y; Takehara T; Tokushige K; Nakajima A; Yoneda M; Saibara T; Shiota G; Sakaida I; Nakamuta M; Mizuta T; Tsubouchi H; Sugano K; Shimosegawa T; ;
J Gastroenterol; 2015 Apr; 50(4):364-77. PubMed ID: 25708290
[TBL] [Abstract][Full Text] [Related]
30. Metabolic disorders across the body mass index spectrum in a Colombian population with nonalcoholic fatty liver disease.
Builes-Montaño CE; Pérez-Giraldo E; Castro-Sánchez S; Rojas-Henao NA; Santos-Sánchez OM; Restrepo-Gutiérrez JC
Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):64-69. PubMed ID: 37088640
[TBL] [Abstract][Full Text] [Related]
31. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.
Pydyn N; Miękus K; Jura J; Kotlinowski J
Pharmacol Rep; 2020 Feb; 72(1):1-12. PubMed ID: 32016853
[TBL] [Abstract][Full Text] [Related]
32. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
Hassan K; Bhalla V; El Regal ME; A-Kader HH
World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi ZM; Henry L; Bush H; Mishra A
Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease in Latinos.
Saab S; Manne V; Nieto J; Schwimmer JB; Chalasani NP
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):5-12; quiz e9-10. PubMed ID: 25976180
[TBL] [Abstract][Full Text] [Related]
35. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.
Araújo AR; Rosso N; Bedogni G; Tiribelli C; Bellentani S
Liver Int; 2018 Feb; 38 Suppl 1():47-51. PubMed ID: 29427488
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis.
Esteban JPG; Asgharpour A
Gastroenterol Clin North Am; 2020 Mar; 49(1):105-121. PubMed ID: 32033758
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
Wang Z; Xu M; Hu Z; Shrestha UK
Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
Maurice JB; Patel A; Scott AJ; Patel K; Thursz M; Lemoine M
AIDS; 2017 Jul; 31(11):1621-1632. PubMed ID: 28398960
[TBL] [Abstract][Full Text] [Related]
39. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
Iqbal U; Perumpail BJ; Akhtar D; Kim D; Ahmed A
Medicines (Basel); 2019 Mar; 6(1):. PubMed ID: 30889791
[TBL] [Abstract][Full Text] [Related]
40. Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective.
Samji NS; Verma R; Satapathy SK
J Clin Exp Hepatol; 2019; 9(4):497-505. PubMed ID: 31516266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
